| Literature DB >> 23593441 |
Je Seon Song1, Dong Hwan Hwang, Seong-Oh Kim, Mijeong Jeon, Byung-Jai Choi, Han-Sung Jung, Seok Jun Moon, Wonse Park, Hyung-Jun Choi.
Abstract
There are histological and functional differences between human deciduous and permanent periodontal ligament (PDL) tissues. The aim of this study was to determine the differences between these two types of tissue at the molecular level by comparing their gene expression patterns. PDL samples were obtained from permanent premolars (n = 38) and anterior deciduous teeth (n = 31) extracted from 40 healthy persons. Comparative cDNA microarray analysis revealed several differences in gene expression between the deciduous and permanent PDL tissues. These findings were verified by qRT-PCR (quantitative reverse-transcription-polymerase chain reaction) analysis, and the areas where genes are expressed were revealed by immunohistochemical staining. The expressions of 21 genes were up-regulated in deciduous relative to PDL tissues, and those of 30 genes were up-regulated in permanent relative to deciduous PDL tissues. The genes that were up-regulated in deciduous PDL tissues were those involved in the formation of the extracellular matrix (LAMC2, LAMB3, and COMP), tissue development (IGF2BP, MAB21L2, and PAX3), and inflammatory or immune reactions leading to tissue degradation (IL1A, CCL21, and CCL18). The up-regulated genes in permanent PDL tissues were related to tissue degradation (IL6 and ADAMTS18), myocontraction (PDE3B, CASQ2, and MYH10), and neurological responses (FOS, NCAM2, SYT1, SLC22A3, DOCK3, LRRTM1, LRRTM3, PRSS12, and ARPP21). The analysis of differential gene expressions between deciduous and permanent PDL tissues aids our understanding of histological and functional differences between them at the molecular level.Entities:
Mesh:
Year: 2013 PMID: 23593441 PMCID: PMC3620385 DOI: 10.1371/journal.pone.0061231
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Quantitative RT-PCR primers used in this study.
| Genes | Primer Assay ID | Product Size (bp) |
|
| Hs01043711_m1 | 79 |
|
| Hs00171076_m1 | 81 |
|
| Hs00198023_m1 | 69 |
|
| Hs00985639_m1 | 66 |
|
| Hs00324954_m1 | 91 |
|
| Hs00611303_m1 | 101 |
|
| Hs03003631_g1 | 69 |
Up-regulated genes in deciduous PDL tissue (compared to permanent PDL tissue).
| Gene Description | Gene Symbol | Fold Change | Gene Accession | Cytoband |
| laminin, gamma 2 |
| 3.25 | NM_005562 | 1q25-q31 |
| cartilage oligomeric matrix protein |
| 3.19 | NM_000095 | 19p13.1 |
| chemokine (C-C motif) ligand 21 |
| 3.13 | NM_002989 | 9p13 |
| peptidase domain containing associated with muscle regeneration 1 |
| 2.76 | NM_015430 | 11p13 |
| chemokine (C-C motif) ligand 18 |
| 2.67 | NM_002988 | 17q11.2 |
| coagulation factor II (thrombin) receptor-like 2 |
| 2.57 | NM_004101 | 5q13 |
| interleukin 1, alpha |
| 2.53 | NM_000575 | 2q14 |
| insulin-like growth factor 2 mRNA binding protein 1 |
| 2.48 | NM_006546 | 17q21.32 |
| Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
| 2.47 | NM_000569 | 1q23 |
| laminin, beta 3 |
| 2.43 | NM_001017402 | 1q32 |
| phosphate-regulating endopeptidase homolog, X-linked |
| 2.19 | NM_000444 | Xp22.2-p22.1 |
| mab-21-like 2 |
| 2.16 | NM_006439 | 4q31 |
| small proline-rich protein 2B |
| 2.10 | NM_001017418 | 1q21-q22 |
| paired box 3 |
| 2.10 | NM_181458 | 2q35-q37|2q35 |
| tetraspanin 2 |
| 2.06 | NM_005725 | 1p13.2 |
| immunoglobulin kappa variable 1–5 |
| 2.05 | ENST00000453166 | 2p12 |
Up-regulated genes in permanent PDL tissue (compared to deciduous PDL tissue).
| Gene Description | Gene Symbol | Fold Change | Gene Accession | Cytoband |
| interleukin 6 (interferon, beta 2) |
| 4.95 | NM_000600 | 7p21 |
| SH3 and cysteine rich domain |
| 4.19 | NM_003149 | 3p22.3 |
| FBJ murine osteosarcoma viral oncogene homolog B |
| 4.02 | NM_006732 | 19q13.32 |
| cellular retinoic acid binding protein 1 |
| 3.74 | NM_004378 | 15q24 |
| ADAMTS-like 3 |
| 3.51 | NM_207517 | 15q25.2 |
| FBJ murine osteosarcoma viral oncogene homolog |
| 2.97 | NM_005252 | 14q24.3 |
| dedicator of cytokinesis 3 |
| 2.91 | NM_004947 | 3p21.2 |
| phosphodiesterase 3B, cGMP-inhibited |
| 2.81 | NM_000922 | 11p15.1 |
| leucine rich repeat transmembrane neuronal 1 |
| 2.71 | NM_178839 | 2p12 |
| ADAM metallopeptidase with thrombospondin type 1 motif, 18 |
| 2.64 | NM_199355 | 16q23 |
| corin, serine peptidase |
| 2.57 | NM_006587 | 4p13-p12 |
| cAMP-regulated phosphoprotein, 21 kDa |
| 2.55 | NM_016300 | 3p22.3 |
| hypothetical LOC644714 |
| 2.50 | BC047037 | 3p21.31 |
| V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
| 2.33 | NM_000222 | 4q11-q12 |
| neural cell adhesion molecule 2 |
| 2.29 | NM_004540 | 21q21.1 |
| sestrin 3 |
| 2.27 | NM_144665 | 11q21 |
| leucine rich repeat transmembrane neuronal 3 |
| 2.26 | NM_178011 | 10q21.3 |
| protease, serine, 12 (neurotrypsin, motopsin) |
| 2.24 | NM_003619 | 4q28.1 |
| calsequestrin 2 (cardiac muscle) |
| 2.21 | NM_001232 | 1p13.3-p11 |
| myosin, heavy chain 10, non-muscle |
| 2.17 | NM_005964 | 17p13 |
| ribosomal protein L21 |
| 2.16 | NM_000982 | 13q12.2 |
| secreted frizzled-related protein 1 |
| 2.13 | NM_003012 | 8p11.21 |
| synaptotagmin I |
| 2.12 | NM_005639 | 12cen-q21 |
| solute carrier family 22, member 3 |
| 2.12 | NM_021977 | 6q25.3 |
| cytochrome P450, family 1, subfamily B, polypeptide 1 |
| 2.11 | NM_000104 | 2p21 |
| jun proto-oncogene |
| 2.08 | NM_002228 | 1p32-p31 |
| small nucleolar RNA, H/ACA box 4 |
| 2.07 | NR_002588 | 3q27 |
| adenylate cyclase 10 pseudogene |
| 2.05 | NR_026938 | 6p21.1 |
Figure 1Main categories of genes expressed specifically in deciduous PDL tissues (de-PDL) and permanent PDL tissues (pe-PDL) on the basis of their biological processes.
Numbers of involved genes are listed in x-axis, F-statistic p<0.05.
Figure 2Main categories of genes expressed specifically in de-PDL and pe-PDL on the basis of their molecular functions.
Numbers of involved genes are listed in the pie charts, F-statistic p<0.05.
The relative gene expressions in the deciduous and permanent PDL tissues.
| Gene | Relative Gene Expression (mean±SE) | |
| Deciduous PDL Tissues | Permanent PDL Tissues | |
|
| 4.90±0.20 | 1 |
|
| 6.02±0.03 | 1 |
|
| 43.78±0.00 | 1 |
|
| 1 | 34.38±0.02 |
|
| 1 | 4.02±0.06 |
|
| 1 | 12.67±0.05 |
SE; standard error.
Figure 3Immunohistochemical (IHC) staining of permanent and deciduous PDL tissues (A–P).
(A, E) IHC staining for IGF2BP1 in permanent and (I, M) deciduous PDL tissues. (B, F) IHC staining for IL6 in permanent and (J, N) deciduous PDL tissues. (C, G) IHC staining for LRRTM1 in permanent and (K, O) deciduous PDL tissues. (D, H) IHC staining for ADAMTSL3 in permanent PDL tissues and (L, P) deciduous PDL tissues. Abbreviations: pe-PDL, permanent PDL tissues; de-PDL, deciduous PDL tissues. Scale bars: 100 µm in A–D and M–P; 20 µm in E–H and I–L.